Are you taking Isosorbide Dinitrate? Are you aware of the dangers of combining Isosorbide Dinitrate with certain foods, herbs, or alcohol? Drug-food-interactions are seldom discussed but can lead to ...

The global isosorbide market exhibited moderate growth during 2015-2020. Also known as D-Isosorbide dinitrate, isosorbide (C6H10O4) is a bio-product obtained from starch. The derivatives of isosorbide ...

Isosorbide mononitrate (ISMN) is the active metabolite of ISDN and is primarily used in the management of chronic stable angina. It is not FDA-approved for treating heart failure. It has high ...

In the quest to replace fossil-based feedstocks for cost-effective equivalents derived from renewable resources, isosorbide has emerged as a promising player. A sustainable and non-toxic diol for ...

After an episode of acute bleeding from esophageal varices, patients are at high risk for recurrent bleeding and death. We compared two treatments to prevent recurrent bleeding — endoscopic ligation ...

DALLAS -- Drugs that improve endothelial function appeared promising for people with lacunar strokes resulting from small vessel disease (SVD), according to LACI-2 study findings that pave the way for ...

Sublingual isosorbide dinitrate, 5 mg, combined with oral propranolol, 40 mg, was given four times daily for six weeks to 23 patients with angina pectoris. The effects were compared with those of ...

The catalytic dehydration of sorbitol to isosorbide has emerged as a critical process in the transition towards sustainable chemical manufacturing. This reaction transforms sorbitol, a readily ...

Cilostazol and isosorbide mononitrate, two widely available drugs that have beneficial effects on endothelial function, appear to improve functional and cognitive outcomes when used in patients who ...

Ahmedabad: Zydus Lifesciences Limited received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Isosorbide Mononitrate Extended-Release, Tablets USP ...

A small Chinese trial compared the effects of three oral antispastic medications for 24 weeks post-coronary artery bypass grafting (CABG) in relation to spasm-induced radial artery graft failure.